Medscape |
First Tx for Erdheim-Chester Disease, a Rare Blood Cancer
Medscape The US Food and Drug Administration (FDA) has approved a treatment for the first time for use in patients with Erdheim-Chester disease (ECD), a rare hematologic malignancy affecting about 600 to 700 patients worldwide. These patients have very limited ... FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer Genentech's Zelboraf Gets FDA Approval in BRAF Mutation-Positive Erdheim-Chester Disease UPDATE 1-FDA approves Roche drugs for rare types of blood, lung cancers |
from Health - Google News http://ift.tt/2hg7hyt
EmoticonEmoticon